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REVIEW OF LITERATURE 
Ivermectin 
Ivermectin (22,23-dihydroavermectin B 1) is a member of the avermectin family. It is 
the drug of choice for the treatment and prevention of many nematode and arthropod 
parasite infections (Chabala et al. 1980; Campbell et al. 1983, 1984, 1991, 1993; Ottesen 
et al. 1994). The anthelmintic activity of the avermectins was first described in 1979 
(Burg et al. 1979; Egerton et al. 1979; Miller et al. 1979). Ivermectin was introduced 
commercially in 1981. 
Structure, physical and chemical characteristics of ivermectin 
Fermentation of the actinomycete Streptomyces avermitilis produces four 
homologous pairs of closely related, complex, 16-membered, macrocyclic lactones: 
avermectin A1, A2, B 1 and B2. Based on the sidechain composition at carbon position 25 
(Fig. 1), the four pairs are further divided into the major components "a" (a secondary 
butyl substituent at C-25, more than 80%) and minor components "b" (an isopropyl 
group, less than 20%). Avermectin B 1a has the highest potency against many of endo-
and ectoparasites of animals, as well as many agricultural mite and insect pests. It is also 
the starting material for synthesizing ivermectin. 
Because it is very difficult and impractical to separate the major components "a" 
from the minor components "b", and because the biological activities of the two 
components are almost indistinguishable, the avermectins are often used as a mixture of 
the two components (more than 80% of component "a", less than 20% of "b"). In such 
cases they are just named as A1, A2, B 1 and B2. Ivermectin (22,23-dihydroavermectin B 1) 
is used as such a mixture. 
The avermectins are highly lipophilic, and dissolve in most organic solvents. Their 
water solubility is correspondingly low - only 6 to 9 ppb (Fisher and Mrozik 1989). 
lvermectin contains two double bonds conjugated as an 8,9,10,11-diene function, 
which results in a strong UV absorption at 245 nm (Fisher and Mrozik 1989). This 
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property is useful in analytical detection. Another consequence is that exposure under 
UV light below 280 nm decomposes ivermectin rapidly (Mrozik et al. 1988). 
Ivermectin is unstable under acidic and basic conditions. The disaccharide motif is 
subject to acidic hydrolysis. Weak acids cleave off the first sugar. Stronger acids are 
necessary to hydrolyze off the second sugar to give the aglycone (Fisher and Mrozik 
1989). The proton at the asymmetric C-2 next to the lactone carbonyl group is acidic. A 
strong base aromatizes the 6-membered ring and opens the lactone ring (Pivnichny et al. 
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1983, 1988). Consequently, strong bases can be used to destroy ivermectin residues for 
safe disposal. 
Application of ivermectin 
Synthetic compounds dominated the anthelmintic market until the late 1970s. The 
discovery of the avermectins changed that dramatically. Ivermectin has been used most 
widely in domestic animals in the control of parasitic diseases that cause losses of 
hundreds of millions of dollars annually. Its use in human medicine has also received 
considerable attention because of its control of onchocerciasis (river blindness), one of 
the most insidious and intractable of tropical diseases. 
Ivermectin is used against a wide range of nematode and arthropod parasites in 
domestic animals (Chabala et al. 1980; Campbell et al. 1983, 1984, 1993), as well as in 
laboratory and exotic mammals and in birds, fish, and reptiles (Soll 1989). Essentially all 
important nematode species are susceptible, both immature and mature stages. In 
addition to its activity against nematode parasites, ivermectin is also active against 
several important ectoparasites, such as grubs, screwworms, lice, mites and ticks. 
Because of its activity against both endoparasitic and ectoparasitic organisms, it has 
become known as the first "endectocide". Ivermectin is active when given orally, 
intramuscularly, subcutaneously, or even topically. 
Ivermectin was first reported in human trials against onchocerciasis in 1982 (Aziz et 
al. 1982a, 1982b). Its clinical trials and usage have been well reviewed (Campbell 1991, 
1993). Its potent microfilaricidal activity against the other major filarial parasites of 
humans has also been recognized (Campbell 1991; Ottesen et al. 1994). Preliminary 
studies have shown that ivermectin is effective against some human intestinal nematodes, 
Ascaris lumbricoides, Strongyloides stercoralis, Trichuris trichiura and Enterobius 
vermicularis, but weak against other species, Ancylostoma duodenale and Necator 
americanus (Campbell 1993). The efficacy of ivermectin against ectoparasitic 
infestations (mites, lice) of humans has also been reported (Ottesen et al. 1994). 
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Antiparasitic effect of ivermectin and mechanism of action 
Ivermectin reduces motor activity of the parasites so that they are excreted from the 
host (Martin 1993). Early electrophysiological studies using muscle or nerve 
preparations from lobsters, insects, large nematodes or mammalian brains (Fritz et al. 
1979; Kass et al. 1980, 1984; Duce and Scott 1985; Mellin et al. 1983; Abalis et al. 1986; 
Albert et al. 1986; Krusek and Zemkova 1994; Huang and Casida 1997) suggested that 
ivermectin interferes with synaptic transmission, and that this is the result of increased 
cell membrane permeability to chloride ions, which is explained by the opening of 
GABA-gated er channels. 
It has recently been shown, however, that ivermectin also activates Cl- channels that 
are not regulated by GABA. Specific ivermectin binding sites have been identified in the 
free-living nematode Caenorhabditis elegans and in mammalian brain tissue. The 
affinity of ivermectin for the nematode site (apparent dissociation constant, ~ = 0.26 
nM), is about 100 times greater than that for the mammalian brain site (Schaeffer and 
Haines 1989). The failure of GABA to compete with ivermectin for binding to the 
nematode (Cully and Paress 1991) suggests that the GABA and ivermectin receptors are 
significantly different. The mode of action of ivermectin has also been studied in 
specially prepared oocytes of the frog Xenopus laevis. After mRNA of C. elegans is 
injected into an oocyte, a Cl- current can be activated in the membrane of the oocyte by 
ivermectin and L-glutamate, but not GABA (Arena et al. 1991, 1992). These studies 
together suggest that GABA plays little, if any, part in the antiparasitic action of 
ivermectin. They also lead to the discovery of a novel type of er channels, namely a 
glutamate-gated ivermectin-sensitive Cl- channel. 
Glutamate-gated ivermectin-sensitive Cl- channels have been described in many 
invertebrates, such as nematodes, insects, crustaceans, and mollusks (Cleland 1996). 
Although their physiological role has not been fully determined, they are reported to be 
involved in generating rhythmic firing of the neurons within the crustacean 
stomatogastric ganglion (Cleland and Selverston, 1995, 1998). Two subunits (GluCla 
and GluCl~) have been cloned from C. elegans (Cully et al. 1994). Gene structure 
comparisons and phylogenetic analyses reveal that these channels are related to 
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vertebrate glycine channels/receptors. Since these channels only exist in invertebrates, 
they may mediate the powerful anthelmintic and insecticidal action of ivermectin, while 
accounting for the low toxicity to mammals. 
Other actions of ivermectin 
It was reported that ivermectin specifically binds to retinal-binding protein isolated 
from parasitic worms of the family Filarioidae, but not the host organism (Sani and Vaid 
1988). lvermectin was also reported to be a specific inhibitor of protein kinase C isolated 
from rat brain (Ellis et al. 1987). The high concentration of ivermectin required for this 
action (IC50 : 1 µM) suggests that this may not be of physiological significance. In 
sarcoplasmic reticulum (SR) of rat and rabbit skeletal muscle, ivermectin directly 
activates ryanodine receptor Ca2+ channels, and reduces Ca2+ uptake by the SR Ca2+ -
Mg2+-ATPase (Ahem et al. 1999). Once again, the high dose of ivermectin (10 µM) may 
not be pharmacologically significant. 
Safety of ivermectin in mammals 
Clinical signs of the acute toxicity of ivermectin in mammals may be related to its 
effect on GABA-gated c1- channels in the mammalian brain and spinal cord. Common 
signs include ataxia, tremors, and in severe cases, coma and death (Lankas and Gordon 
1989; Pulliam and Preston 1989). Rodents are more sensitive to ivermectin toxicity than 
are other species. Severe reactions and death occur in mice at dosages as low as 200 
µg/kg- the dosage that is routinely used in treating parasitic nematodes in animals and 
onchocerciasis in human (LD50 = 25 mg/kg) (Campbell 1993). However, doses of 2.0 
mg/kg or higher are needed for acute toxicity in other species, such as rats, rabbits, rhesus 
monkeys, horses, cattle, sheep, goats, swine and dogs (Lankas and Gordon 1989; Pulliam 
and Preston 1989). 
Results of some subchronic, developmental and reproductive toxicity studies are 
summarized in Table 1 (Lankas and Gordon 1989). It is concluded that ivermectin is 
well tolerated in most mammals. 
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Table 1. No-observed-effect level (mg/kg/day) of toxicity studies with ivermectin 
Species Subchronic studies Developmental and reproductive studies 
0.1 Mouse - (maternotoxicity) 
Rat 0.4 5.0 (maternotoxicity (splenic enlargement) and developmental toxicity) 
Rabbit 1.5 - (developmental toxicity) 
Dog 0.5 (mydriasis) -
Rhesus monkey >1.2 (treatment-related effects) -
Environmental fate and concern of ivermectin 
When ivermectin is administered (orally, topically, or subcutaneously) to food-
producing animals, the drug enters the environment as a result of excretion. Most of it (at 
least 90%) is excreted as intact drug in the feces of the treated animal. The remainder is 
excreted in urine (Campbell 1993). 
The distribution and movement of a chemical in the environment depends on the 
compound's physical and chemical properties. Ivermectin's low water solubility predicts 
tight binding to soils, as evidenced by the high partition coefficient (Ko = concentration 
in soil / concentration in water = 227 to 333) and high organic-carbon binding constant 
(Koc = 12,600 to 15,700) (Halley et al. 1989). The strong soil binding results in the 
minimal leaching into ground water. But run-off in surface water with eroding sediments 
should be expected. 
Ivermectin is degraded by sunlight and soil microbes. Depending on the 
environmental conditions, the degradation half-life of ivermectin varies from 7 - 14 d in 
summer to 91 - 217 d in winter (Halley et al. 1989). 
Because of its potent antiparasitic effect mediated through glutamate-gated c1-
channels, which are present in many invertebrates (Cleland 1996), ivermectin raises 
concerns about its impact on non-target organisms, especially invertebrates, and 
associated environmental consequences. It has been shown that dung from ivermectin-
treated animals failed to degrade in the normal way and this failure was associated with 
-
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the absence of dung-degrading invertebrate community, which includes many species of 
insects and oligochaetes (Wall and Strong 1987; Strong 1993). This may exert a threat to 
pastureland ecology. 
Although lethal levels of ivermectin have been determined in some non-target 
organisms - daphnia, fish, earthworms, birds and insects (Halley et al. 1993), the effects 
of sub lethal doses have hardly been recognized at the present time. In the present study, 
we examined the lethal and sublethal behavioral and electrophysiological effects of 
ivermectin in a freshwater oligochaete, Lumbriculus variegatus. 
Freshwater oligochaete, Lumbriculus variegatus 
Blackworms, Lumbriculus variegatus (Phylum Annelida, Class Oligochaeta), are 
common in ponds, lakes, and marshes of North America and Europe. They freely crawl 
within and feed on submerged and decaying vegetation, such as rotting leaves and logs 
(Drewes and Fourtner 1989). 
Locomotor behaviors in L. variegatus 
Generally, L. variegatus moves toward food sources and away from strong light and 
open spaces. When suddenly touched or threatened, it uses a variety of responses to 
move to safety. The first response, seen when worms are covered or in contact with 
substrate, is an escape reflex involving rapid body shortening and withdrawal of the 
worm's head or tail end. However, other reflex responses may occur depending on the 
worm's environmental context. On wet surfaces or in confined spaces under water, 
worms crawl forward or backward when lightly touched at tail or head end, respectively. 
However, when worms are submerged in "open water" condition, tail stimulation evokes 
rhythmic waves of helical swimming, while head stimulation evokes a body reversal 
response (Drewes, 1999a). Each of these reflex behaviors is apparently controlled by a 
different neural pathway (Fig. 2). 
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Figure 2. Diagram of neural pathways in L. variegatus and locomotor 
behaviors controlled by different neural pathways 
Giant-interneuron pathways and escape reflex 
Rapid escape responses in oligochaetes are mediated by two independent giant 
intemeuron pathways, the medial giant fiber (MGF) system and the lateral giant fiber 
(LGF) system (Drewes 1984; Zoran and Drewes 1987; Drewes and Fourtner 1989; 
Drewes and Brinkhurst 1990). Both MGF and LGF pathways consist of tandemly 
aligned large caliber axons derived from intemeurons in each segment. The tandem 
axonal units are connected at intersegmental boundaries by electrical synapses (gap 
junctions). These connections cause the fibers to act as a functional syncytium, allowing 
uninterrupted conduction of action potentials along the whole length of the ventral nerve 
cord (Drewes 1999b ). The MGF is excited by tactile stimulation to the anterior 30% of 
the worm's body, while the sensory field for the LGF extends over the posterior 70% of 
the body (Drewes and Fourtner 1990). The LGF is also excited by photosensory inputs 
(Drewes and Fourtner 1989). In each segment the giant fibers activate motor neurons, 
which innervate body wall longitudinal muscles and bring about body shortening 
(Drewes 1999b ). 
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Non-giant interneuron pathways and other locomotor behaviors 
Tactile stimulation anywhere within the posterior one-half of the worm consistently 
evokes swimming responses when the worm is in "open water" conditions. Swimming 
movements consist of a series of alternating left-handed and right-handed, rapid and 
rhythmic waves of helical body bending. Each wave rapidly progresses from head to tail, 
thus propelling the worm forward (Drewes 1999a). 
Touching to anterior segments while in "open water" evokes body reversal, which 
consists of a stereotyped sequence of bending movements that effectively reverses head 
and tail positions. Although there is little net movement of the body center, reversal may 
reposition the head away from the predatory threat and prepare the worm for swimming 
away from the threatening stimulus (Drewes 1999a). 
Crawling movements are seen when the worm is in substantial contact with substrate 
or sediment, thus restricting other movements, such as swimming. Crawling consists of a 
series of rhythmic peristaltic waves of circular and longitudinal muscle contraction. Each 
wave begins at the anterior or posterior end and rapidly progresses posteriorly or 
anteriorly along the body (forward or backward crawling, respectively). 
The specific network of neurons in an animal's nervous system that controls 
rhythmic movements, such as the worm's swimming and crawling, is called a central 
pattern generator (Young 1989; Drewes 1999b). Central pattern generators for 
locomotion in invertebrates, such as annelids and arthropods, are usually in the ventral 
nerve cord but do not involve giant nerve fibers. 
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LETHAL AND SUBLETHAL EFFECTS OF 
IVERMECTIN IN A FRESHWATER OLIGOCHAETE, 
LUMBRICULUS VARIEGATUS 
Introduction 
Ivermectin, (22, 23-dihydroavermectin B 1a), a semisynthetic avermectin analog, is a 
potent anthelmintic and insecticide against nematode and arthropod parasites. It is 
widely used to improve the health care of livestock and companion animals (Chabala et 
al. 1980; Campbell et al. 1983, 1984, 1993). Its use also extends to human medicine 
(Campbell et al. 1991; Ottesen et al. 1994). Although ivermectin's mode of action is not 
fully understood, it is generally believed that ivermectin reduces excitability of muscle or 
nerve through the opening of CC channels (Arena et al. 1995; Brownlee et al. 1997; Duce 
& Scott 1985; Kass et al. 1980; Martin et al. 1997). 
The environmental effects and fates of ivermectin have also been studied (Halley et 
al. 1989, 1993; Roncalli 1989; Strong 1993; Wall & Strong 1987). In the vast majority 
of these studies, mortality has been the endpoint. Daphnia magna was particularly 
sensitive to ivermectin with 48 h LC50 of 0.025 ppb (~ 0.03 nM, Halley et al. 1993). Fish 
were less sensitive [48 h LC50 for bluegill (Lepomis macrochirus) and rainbow trout 
(Oncorhynchus mykiss) were 4.8 ppb and 3.0 ppb, respectively], and earthworms (Eisenia 
foetida, 28 d LC50 315 ppm in soil) were relatively insensitive to ivermectin (Halley et al. 
1993). Without analysis of sublethal end-points (e.g., effects on growth, development, 
fecundity, morphology, behavior, or physiology), we can not fully understand the 
complex biological actions or predict ecological impacts of environmental toxicants. 
This is especially true for a chemical like ivermectin, which exerts antiparasitic effects 
not by immediately killing the target organisms but by reducing their motor activities so 
that the parasites are excluded from the host (Martin 1993). 
Among a few studies concerning sublethal effects of ivermectin on non-target 
organisms, most have examined development and reproduction, especially in dung-
dwelling insect populations, that may be threatened by drug residues in the manure from 
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ivermectin-treated animals (Halley et al. 1993). Ivermectin residues inhibited larval 
development of bushfly, M vetustissima and M. domestica (Wardhaugh et al. 1993, 
1996; Wardhaugh and Mahon 1998). Adult dung beetles (C. hispanus, Bubas bubalus, 
or Onthophagus binodis) survived exposure to dung containing ivermectin residue, but 
the rate of oviposition was reduced (Ridsdill-Smith 1988, 1993; Wardhaugh and 
Rodriguez-Menendez 1988). 
Locomotor capabilities are logical focal points for studies of sublethal effects of 
ivermectin, because the most predominant effects shown in target organisms are reduced 
motor activities (Martin 1993). However, effects of ivermectin on motor activity on non-
target organisms are poorly understaood. In this study, we examined sublethal effects of 
ivermectin on locomotor behaviors of a non-target invertebrate, Lumbriculus variegatus 
(Family Lumbriculidae, common name: mud worm, blackworm). 
Features that make L. variegatus especially suitable for this study include: (i) their 
ubiquitous inhabitation in North America and Europe, and introduction into Africa, 
Australia, and New Zealand (Brinkhurst and Jamieson 1971); (ii) their freshwater benthic 
habitat, in which they are vulnerable to the possible runoff of ivermectin within eroding 
sediments; (iii) their ease in laboratory rearing, maintenance and handling; (iv) their 
defined patterns of locomotor behaviors, namely helical swimming, body reversal 
(Drewes 1999a), and crawling (Drewes and Cain 1999); (v) the presence of giant nerve 
fibers (intemeurons) that mediate rapid escape responses (Drewes 1984; Drewes and 
Fourtner 1989; Drewes and Brinkhurst 1990); (vi) and the capability of non-invasive 
electrophysiological testing of escape reflex function (Drewes 1984; Zoran and Drewes 
1987; Rogge and Drewes 1993). 
Our specific objectives were to: (i) determine lethal concentrations of ivermectin in 
L. variegatus; (ii) examine sublethal effects of ivermectin on locomotor behaviors: 
swimming, reversal and crawling; (iii) verify the involvement of Cl- channels using 
picrotoxin, a Cl- channel blocker, and (iv) examine electrophysiologically the effects of 
ivermectin on giant nerve fiber pathways. 
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Methods and Materials 
Materials 
The following chemicals were used: ivermectin stock solution (10 mg/ml in 40% 
glycerol formal and 60% propylene glycol, Merck AgVet, Rahway, NJ) and picrotoxin 
(Sigma Chemical Co., St. Louis, MO). 
Animal maintenance and selection 
L. variegatus were reared in the laboratory from asexually reproducing colonies. 
The worms were kept in aerated aquaria containing pieces of brown paper towel (21 -
23°C) and fed three to five times per week with sinking fish food. 
Medium-sized worms (::::; 4 - 5 cm long) were removed from rearing tanks 12 - 24 h 
prior to testing and placed in Petri dishes containing distilled water to allow clearance of 
gut contents. Worms were visually screened for uniformity in segmentation pattern. 
Worms showing recent segment regeneration or any obvious morphological defects were 
not used. 
Treatment 
Ivermectin solutions were prepared by diluting ivermectin stock solution in distilled 
water. Additional propylene glycol was added to all the solutions of lower ivermectin 
concentrations so that the volume of vehicle in all solutions was the same. Control 
solutions also had the same volume of vehicle as the ivermectin solutions. In ivermectin 
and picrotoxin antagonism experiments, picrotoxin was dissolved in distilled water. 
After worms were exposed in the picrotoxin solutions for 60 min, ivermectin and/or 
propylene glycol were added to the solutions. Concentration levels of ivermectin and/or 
picrotoxin were determined according to preliminary range-finding experiments (Table 
2). All concentrations reported are nominal; no analytical procedures were performed to 
verify the actual concentrations of the chemicals. However, all aqueous solutions were 
freshly prepared immediately before the experiments. 
13 
Table 2. Treatments used in the present study 
Experiment Treatments 
LCso Ivermectin: 180, 320, 560, 1000, 1800 nM 
Swimming and reversal Ivermectin: vehicle, 0.3, 3, 30, 300 nM 
Swimming frequency Ivermectin: vehicle, 0.03, 0.3, 3, 30 nM 
Antagonism by picrotoxin of All combinations of two levels of ivermectin (vehicle, 30 nM) and six levels of picrotoxin ivermectin on swimming frequency (0, 1, 10, 100, 1000, 10000 nM) 
Crawling frequency and speed Ivermectin: 0, 10, 30, 100, 300 nM 
Antagonism by picrotoxin of All combinations of two levels of ivermectin 
ivermectin on crawling frequency and (vehicle, 300 nM) and six levels of 
speed picrotoxin (0, 1, 3, 10, 30, 100 µM) 
Treatment was carried out in covered glass Petri dishes (9 cm in diameter, 2 cm in 
depth) with one worm per container of 100 ml (for swimming and reversal tests) or 50 ml 
(for other tests) solution. Individual worms were randomly assigned to the treatments. 
Each treatment was replicated ten to 21 times. In swimming and reversal tests, the 
worms were examined directly in the treatment dishes. In other tests (swimming 
frequency, crawling and electrophysiology), the worms were quickly rinsed twice in 
distilled water and temporarily removed from the treatment dishes for behavioral or 
electrophysiological testing. 
Lethal effect 
Fifty worms were randomly assigned to five treatments (Table 2), ten 
worms/treatment. Observations were made after 24 and 72 h of exposure. Mortality was 
determined as decomposition of the worms. 
Behavioral testing 
Swimming and Reversal 
Helical swimming and body reversal behaviors in L. variegatus were studied as 
previously described (Drewes 1999a). The worms' ability to initiate swimming and/or 
reversal episodes was tested before and at various times after treatment (0, 1, 3 and 8 h). 
-
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In each test, a worm was touched ten times with a thin rubber probe alternately at its 
anterior or posterior end to evoke reversal and swimming, respectively. The interval 
between successive touches was three to five seconds. A response to a touch stimulus 
was scored as successful only when the worm showed stereotypical patterns of swimming 
or reversal movements. 
Swimming frequency and pattern 
To quantify possible effects of ivermectin on swimming frequency, a worm was 
placed in the middle of a plastic Petri dish (14 cm in diameter, 2.5 cm in depth) 
containing 200 ml of distilled water. Swimming responses were evoked twice by tactile 
stimulation to the posterior end of the worm using a rubber probe (Drewes 1999a). The 
worm was allowed to rest about 2 min after it was moved into the dish and between the 
two trials. The process was recorded on VHS videotape using a video cassette recorder 
(MITSUBISHI, model HS-U650) connected to a camcorder (LXI, model 934.53796290), 
and replayed frame-by-frame on a video monitor (NEC, model XM-2950) after testing to 
examine the swimming pattern and frequency (number of helical body waves produced 
per second). Each worm's responses were measured before and at a selected time after 
treatment (0 and 3 h in ivermectin-alone experiment, 0 and 1.5 h in ivermectin-picrotoxin 
antagonism experiment). The ratio of the mean frequency after treatment to the mean 
frequency before treatment was defined as relative swimming frequency for each worm. 
When exposed to higher concentrations of ivermectin, some worms failed to swim in one 
trial or both trials. In such cases, only successful trials were used to calculate relative 
swimming frequency. If the worm failed twice, the failures were recorded as a separate 
category. These failures were not used for calculation of mean swimming frequency. 
Crawling 
In the crawling test, a worm was placed next to a smooth strip of Plexiglass (180 x 
40 x 6 mm) which rested on a piece of thoroughly wetted filter paper (Whatman #1). 
Any excess water was removed, thus confining the worm within the surface tension of a 
narrow band of water between the Plexiglass and paper. A straight rubber band (5 mm 
long, 0.5 mm in diameter, attached to a wooden applicator stick) was used to brush the 
worm's tail, so the worm would crawl forward in a straight line along the Plexiglass. The 
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frequency of brushing was 3.6 ± 0.1 strokes/sec (n = 20) as determined from videotape 
replay. This stimulation lasted 10 - 15 sec, or until the worm had crawled 4 - 6 cm. The 
same procedure was repeated once, and the worm was allowed to rest for about 1 minute 
between trials. Crawling behavior was recorded on videotape, and later replayed, frame-
by-frame, after testing to measure the crawling speed (distance moved per second) and 
frequency (number of peristaltic waves of contraction produced per second). Each trial 
consisted of one to three episodes of continuous crawling movements. Episodes that had 
relatively constant crawling frequency were used to calculate speed and frequency. Only 
the episode with the highest crawling speed was used for analysis. Each parameter was 
measured twice, once before (0 min) and once after the treatment (15, 30, 60, 120 or 180 
min in ivermectin-alone experiment, 90 min in ivermectin-picrotoxin antagonism 
experiment). Each of these values represents the highest value obtained from one to six 
episodes performed by each worm. Relative crawling frequency and relative crawling 
speed were defined as previously described for relative swimming frequency. 
Electrophysiological testing 
Techniques for noninvasive electrophysiological recording were used as previously 
described (Drewes, 1984; Zoran and Drewes, 1987; Rogge and Drewes, 1993). Briefly, a 
worm was placed next to a smooth strip of Plexiglass ( 4 x 1 cm) on a printed circuit 
board recording grid. Excess water was removed, thus trapping the worm in surface 
tension along a narrow band of water between the Plexiglass and electrode grid. The 
worm's giant fiber system was activated indirectly through sensory stimulation or 
directly through electric stimulation. Evoked spikes, as well as muscle potentials, were 
detected by two pairs of recording electrodes. Signals were amplified, filtered and 
displayed as two channels on a digital oscilloscope (TENMA, model 72-915 20MHz). 
Conduction velocity of giant fibers 
The worms' medial and lateral giant fiber (MGF and LGF) systems were activated 
by tactile stimulation to the anterior and posterior ends of the worms, respectively. Giant 
fiber conduction velocity was measured at a mid-body location over a 10 mm conduction 
distance. To obtain velocity, conduction distance was divided by conduction time, as 
16 
indicated on the oscilloscope screen by the peak-to-peak interval between spikes in the 
two recording channels. Each worm was measured before and after the treatment (0 and 
3 h). Mean velocity (five measurements per worm) was then converted to relative 
conduction velocity, which was defined as the ratio of the mean velocity at any time after 
treatment compared to the mean velocity in the same worm before treatment. Therefore, 
by definition, the relative velocity before treatment in each worm was 1.0. 
Muscle potentials 
Using one pair of metallic electrodes on the grid surface, twin pulses ( duration 100 
µs, inter-pulse interval 10 ms) from an electronic stimulator (Model SD9, Grass Medical 
Instruments, Quincy, MA) were applied to the anterior end of a worm. The voltage of the 
pulse was adjusted so that only MGF spikes, but not LGF spikes, were evoked. Peak-to-
peak amplitude of the muscle potential associated with the second of the two evoked 
MGF spikes was measured on the oscilloscope screen. To account for variation in signal 
attenuation, muscle potential amplitudes were referenced to the average amplitudes of the 
all-or-none MGF spikes. Usually, the ratio between the amplitude of the muscle potential 
and the amplitude of the MGF spike is 0.72 ± 0.08 (n = 10). Duplicate measurements of 
this ratio from each worm were obtained before and after treatment (0 and 3 h), and then 
expressed as a relative value (mean ratio after treatment / mean ratio before treatment = 
relative muscle potential). 
Data analysis 
Mean lethal concentration (LC50) and 95% confidence interval were calculated using 
the method described by Well (Well 1952). Mean inhibitory concentrations (IC50) were 
calculated using a computer program (phrmcalc.bas). 
In all cases, including figures, parametric data were expressed as means ± SEM and 
analyzed by ANOV A. The conservative F value was used to establish significance for 
the treatment effect. Then the least significant difference test was used to determine 
significance of each concentration level. In picrotoxin and ivermectin antagonism 
experiments, data were analyzed using the SAS Proc General Linear Means (GLM) 
procedure. Significance of interaction between ivermectin and picrotoxin was 
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established using two-way factorial analysis. Simple effect comparisons were then used 
to evaluate significance of each concentration level of picrotoxin. x2 -test was used to 
evaluate significance of the non-parametric swimming pattern change. The significance 
level was set at P < 0.05. 
Results 
Lethal effect 
lvermectin concentrations of 560 nM or higher were lethal to worms (Fig. 3). LCso 
at 72 h post-ivermectin treatment was 560 nM (95% confidence interval: 440 - 720 nM). 
A characteristic of ivermectin's lethal effect in L. variegatus was that the concentration 
range for 0 - 90% death was narrow, only representing a three-fold difference. It was 
also evident that onset of ivermectin-induced mortality in L. variegatus was rather 
delayed. At a concentration of 1000 nM and 1800 nM, only one and three out of ten 
treated worms, respectively, died within 24 h of exposure. Most worms (eight and six, 
respectively) died between 24 and 72 h after treatment. In another experiment, ten 
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worms were treated with 2,400 nM (extrapolated 72 h LC99) ivermectin for 8 h, and then 
transferred to distilled water. All of them recovered. 
Sublethal effects 
Our subsequent experiments focused on ivermectin's sublethal effects (0.03 nM -
300 nM). During the first hour after exposure to 300 nM ivermectin, worms became 
flaccidly paralyzed. The worms ' bodies became thinner and longer. Spontaneous 
movement was totally inhibited, as well as swimming, reversal and crawling. In worms 
exposed to lower concentrations of ivermectin, the effects were similar, but less extreme 
and more delayed in onset. In contrast to the ivermectin effects on slow locomotor 
movements, rapid escape reflexes appeared less affected by these exposures (see last 
section ofresults). 
Effect of ivermectin on locomotor behaviors controlled by non-giant-
interneuron pathways 
Swimming and reversal 
Ivermectin inhibited helical swimming and body reversal behaviors in a time- and 
concentration-dependent manner (Fig. 4). There were no observable behavioral changes 
within 10 min of exposure to 300 nM ivermectin. But within 60 min of ivermectin 
administration, swimming and reversal were abolished. Ivermectin at 30 nM also 
abolished swimming (within 3 h) but not reversal. The IC50 at 3 h for swimming and 
reversal were 1.1 nM and 16 nM, respectively. 
Swimming frequency and swimming pattern 
Normal swimming movements consist of a series of alternating left-handed and 
right-handed, rapid, and rhythmic waves of helical body bending. Each wave rapidly 
progresses from head to tail, thus propelling the worm forward (Drewes 1999a). The 
swimming frequency in untreated worms was remarkably consistent, 10.7 ± 0.1 Hz (n = 
80). Ivermectin at 0.3 nM or higher significantly decreased the swimming frequency 3 h 
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Figure 4. Time- and concentration-dependent inhibition of ivermectin on helical swimming 
and body reversal behaviors in Lumbriculus variegatus . A: Effect of ivermectin on 
swimming during 8 h continuous treatment. B: Effect of ivermectin on reversal during 8 h 
treatment. C: Concentration-dependent inhibiting effects of ivermectin on swimming and 
reversal after 3 h treatment. Values are mean± SEM (n = 10). 
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after treatment (Fig. 5). At a concentration of 30 nM, six out of 16 worms failed to swim. 
There were qualitative changes in the basic pattern of swimming in another three worms. 
In these worms, helical waves appeared to initiate from the middle of the body rather 
than from the anterior end. In the remaining seven worms, there was no qualitative 
change in swimming pattern, but the swimming frequency was further decreased (Fig. 5). 
Picrotoxin, a er channel blocker, was used to assess its possible influence on 
ivermectin-induced decreases in swimming frequency and changes in swimming pattern. 
The worms were pretreated with picrotoxin (0, 1, 10, 100, 1000 or 10000 nM) for 60 min 
before ivermectin was added (vehicle only or 30 nM) for 30 min. Picrotoxin alone had 
no effect on swimming frequency (Fig. 6) . Ivermectin decreased swimming frequency by 
4% in picrotoxin 0 groups (the difference between the first dotted and open bars, P < 
0.05). The differences were also significant at picrotoxin 1 and 10 nM groups, but not 
100, 1000 and 10000 nM groups. However, when compared the differences of picrotoxin 
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Figure 6. Antagonism of picrotoxin on ivermectin-induced decrease in swimming frequency 
in Lumbriculus variegatus . A: Effect of picrotoxin. The worms were pretreated with 
picrotoxin for 60 min before ivermectin administration for 30 min. * P < 0.05, compared to 
vehicle only group at the same picrotoxin level. B: Effect of picrotoxin on ivermectin-
induced decrease in swimming frequency. Data were derived from panel A (Bar heights are 
the differences between vehicle only and ivermectin groups at each picrotoxin concentration). 
* P < 0.05, compared to picrotoxin 0 level. Values are mean± SEM (n = 20). 
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100, 1000 and 10000 nM groups to that of picrotoxin 0 groups, only 100 and 1000 nM 
groups were significantly different. 
Picrotoxin also antagonized the ivermectin-induced changes in the qualitative pattern 
of swimming (Table 3). Picrotoxin alone did not cause significant changes. Ivermectin 
at 30 nM caused abnormal swimming pattern in six of 20 worms. Picrotoxin at 10 and 
100 nM significantly reversed the effect of ivermectin. However, higher concentrations 
ofpicrotoxin (1000 and 10000 nM) did not significantly antagonize the pattern changes. 
Table 3. Antagonism by picrotoxin of ivermectin-induced change of swimming pattern 
in Lumbriculus variegatus. 
Ivermectin 
Picrotoxin (nM) 
0 1 10 100 1,000 10,000 
Vehicle 0/20a 0/20 0/20 0/20 1/20 1/20 
30nM 6/20 3/20 0/20 b 1/20 b 2/20 7/20 
The worms were pretreated with picrotoxin for 60 min before ivermectin administration 
for 30 min. 
a number of worms out of 20 that showed abnormal swimming patterns 
b P < 0.05, compared to the 30 nM ivermectin, 0 picrotoxin group 
Crawling 
Forward crawling movements consist of a series of rhythmic peristaltic waves of 
body contraction. Each wave begins at the anterior end and progresses toward the tail. In 
contrast to swimming frequency, there was a great variation in wave frequency and 
forward velocity of crawling. We attempted to reduce this variation by using only the 
most vigorous crawling episodes for each worm. We found that one way to minimize the 
variation in crawling frequency and speed was to stimulate the worms to crawl as fast as 
possible. To do this, we repetitively brushed the worms' tails at a frequency of 3 - 4 
strokes/ second. 
In untreated worms, the crawling frequency and crawling speed were 1.21 ± 0.02 Hz 
and 6.1 ± 0.1 mrn/s, respectively (n = 127). Ivermectin decreased crawling frequency in 
23 
a time- and concentration-dependent manner (Fig. 7). Crawling was totally inhibited 
after 3 h exposure to 300 nM ivermectin. IC50 at 3 h for crawling frequency was 91 nM. 
Picrotoxin antagonized the ivermectin-induced decrease in crawling frequency. The 
worms were pretreated with picrotoxin (0, 1, 3, 10, 30 or 100 µM) for 60 min before 
ivermectin co-exposure (vehicle only or 300 nM) for 30 min. Picrotoxin alone at all 
concentrations studied did not change crawling frequency (Fig. 8). Ivermectin at 300 nM 
significantly decreased crawling frequency by 47% in picrotoxin 0 group. Picrotoxin (3 
and 10 µM) significantly antagonized the effect of ivermectin. However, picrotoxin at 1, 
30, and 100 µM failed to do so (Fig. 8). 
Ivermectin' s inhibitory effect on crawling speed was similar to its effect on crawling 
frequency (Fig. 9). IC50 for crawling speed at 3 h was 51 nM. Ivermectin-induced 
decrease in crawling speed was significantly reduced from 52% to 19% by 10 µM 
picrotoxin (Fig. 10). 
Effect of ivermectin on behavior controlled by giant-interneuron 
pathways 
The worms retained escape reflex function throughout the 3 h of treatment with 300 
nM ivermectin. That is, while crawling on substrate, worms were capable of rapidly 
withdrawing head or tail in response to tactile stimulation. However, responses were 
different from those in normal worms in two ways. First, the escape response was not 
followed by any slower locomotor movements (swimming, reversal or crawling), which 
usually occurred immediately after escape responses in normal worms. Second, while 
normal worms had little difficulty in rapid withdrawing in response to repeated tactile 
stimulation, the escape withdrawal in treated worms was hardly noticeable after four or 
five repeated stimuli. When the worms were allowed to rest for 1 or 2 min, their escape 
reflex reinstated. 
MGF and LGF spiking, recorded noninvasively, was used as an indicator of the 
function of giant-intemeuron pathways. In untreated worms, conduction velocity of 
MGF and LGF was 8.8 ± 0.1 m/s and 6.4 ± 0.1 mis (n = 60), respectively. Ivermectin up 
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Figure 10. Antagonism of picrotoxin on ivermectin-induced decrease of crawling speed in 
Lumbriculus variegatus . A: Effect of picrotoxin. The worms were pretreated with 
picrotoxin for 60 min before ivermectin administration for 30 min. * P < 0.05, compared to 
vehicle only groups at the same picrotoxin level. B: Effect of picrotoxin on ivermectin-
induced decrease of crawling speed. Data were derived from panel A (Bar heights were the 
differences between vehicle only and ivermectin groups at each picrotoxin concentration). * 
P < 0.05, compared to picrotoxin 0 level. Values are mean± SEM (n = 10). 
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300 nM did not change either MGF or LGF conduction velocity (Fig. 1 lA and 11B). 
There were also no noticeable changes related to the function of sensory inputs and motor 
output associated with the giant fiber pathways, i.e. , no changes were observed in the 
sensitivity to tactile stimulation, or muscle potentials associated with multiple spiking in 
the MGF (Fig. 11 C). 
Discussion 
Numerous environmental fate and effect studies on non-target organisms have been 
carried out in the development of ivermectin as an antiparasitic agent (Campbell 1989; 
Halley et al. 1993). Lethal level has been determined in some non-target organisms. 
Among them, Daphnia magna was most sensitive with 48 h LC50 of 0.025 ppb (= 0.03 
nM, Halley et al. 1993). Fish were less sensitive (48 h LC50 for bluegill and rainbow 
trout were 4.8 ppb and 3.0 ppb, respectively), and earthworms (28 d LD50 315 ppm in 
soil) were relatively insensitive to ivermectin (Halley et al. 1993). Our results showed 
that L. variegatus was much less sensitive to ivermectin than Daphnia magna and fish 
(72 h LC50 of 560 nM ~ 490 ppb ), but much more sensitive than earthworms. However, 
there were differences between the exposure method (aqueous solution vs. soil) and time 
scale (3 d vs. 28 d), which makes the comparison to earthworms less meaningful. 
Although the most predominant effects shown in target organisms are reduced motor 
activities, there are few studies in the literature examining sub lethal effects of ivermectin 
on non-target organisms. Among a few studies concerning sublethal effects of ivermectin 
on non-target organisms, most have examined development and reproduction in dung-
dwelling insect populations (Halley et al. 1993). The present study was the first attempt 
to examine the effects of ivermectin on locomotor behaviors of a non-target invertebrate, 
L. variegatus. 
We developed a set of methods to measure the locomotor behaviors in L. variegatus. 
These worms are benthic inhabitants in ponds, lakes, and marshes of North America and 
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Figure 11. Effects of ivermectin on giant-intemeuron pathways in Lumbriculus variegatus. 
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Europe. They freely crawl within submerged and decaying vegetation, such as rotting 
leaves and logs (Drewes and Fourtner 1989). When touched or threatened, these worms 
use a variety of locomotor responses to move to safety. Their responses are context 
specific. When the worm's tail is extended above the sediments, it responds to the tactile 
stimulation or shadow by a rapid withdrawal ( escape response). On wet surfaces or in 
confined spaces under water, the worm crawls forward or backward when touched in tail 
or head regions, respectively. In open spaces under water, however, tail stimulation 
evokes helical swimming, while head stimulation evokes body reversal (Drewes 1999a). 
These locomotor behaviors are highly stereotyped, thus making them ideal for sublethal 
toxicological tests (see Materials and Methods). The presence of giant nerve fibers that 
mediate escape response (Drewes and Fourtner 1989; Drewes and Brinkhurst 1990) and 
the capability of noninvasive electrophysiological testing (Drewes 1984; Zoran and 
Drewes 1987; Rogge and Drewes 1993) provide us with additional advantages in 
accessing sub lethal effects of neurotoxicants, such as ivermectin. 
Our results showed that ivermectin impaired the worm's locomotor behaviors. The 
behavioral endpoints were much more sensitive than LC50. LC50 at 72 h was 560 nM, 
while 3 h IC50s for swimming, reversal, crawling speed and crawling frequency were 1. 1, 
16, 51 and 91 nM, respectively. At 0.3 nM (lower than LC50 by more than three orders of 
magnitude), ivermectin decreased swimming frequency significantly. The differences in 
sensitivity to ivermectin suggested that motor behaviors in L. variegatus are probably 
independent. Therefore, it is important to have multiple measurements to obtain an 
overall picture of the effect of ivermectin. Our results demonstrated that L. variegatus is 
a sensitive model for assessing sublethal locomotor behavioral effects of environmental 
toxicants on aquatic invertebrates. 
It was noted that the onset of paralytic effect of ivermectin in L. variegatus was 
rather delayed. Within 10 min of exposure to 300 nM ivermectin, there was no 
observable behavioral change. It is in sharp contrast to some other neuroactive chemicals, 
e.g. 4-aminopyridine, cadmium chloride, carbofuran, chloroform and diazinon, which 
caused behavioral changes in L. variegatus almost immediately upon exposure ( < 1 min) 
(Rogge and Drewes 1993). It was evident that the onset of ivermectin-induced mortality 
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in L. variegatus was also delayed. A possible explanation for the slow actions of 
ivermectin is the availability of the chemical to the worms. Although ivermectin is 
lipophilic, it is a relatively large molecule (MW :::::: 870) compared to 4-aminopyridine, 
cadmium chloride, carbofuran, chloroform and diazinon (MW: 94, 183, 221, 119 and 
304, respectively). Therefore, it might be difficult for ivermectin to penetrate the worm's 
cuticle. Nevertheless, it is also likely that some of the biological processes involved in 
ivermectin's paralytic and lethal effects are delayed or slowly developing. These 
processes are still elusive. 
Although the mode of action of ivermectin is not fully understood, many studies 
have demonstrated that Cl- channels are involved in its antiparasitic effects (Arena et al. 
1995; Brownlee et al. 1997; Duce & Scott 1985; Kass et al. 1980; Martin et al. 1997). In 
the present study we used picrotoxin, a Cl- channel blocker, to antagonize ivermectin's 
effects on locomotor behaviors. Our results were consistent with the involvement of c1-
channels. However, the antagonism of picrotoxin to ivermectin was only effective in a 
limited range of concentration (Fig. 6, 8, 10 and Table 2) and time scales. In our 
preliminary experiments, picrotoxin failed to reverse ivermectin-induced effects on 
swimming and crawling if the exposure to ivermectin lasted 3 h. A possible explanation 
is that picrotoxin at high concentrations has some additional effects mediated by action 
sites other than Cl- channels. Ivermectin (:-s; 300 nM) had no effects on MGF-evoked 
muscle potentials (Fig. SC), but picrotoxin at 100 µM alone decreased the muscle 
potentials (unpublished data). Picrotoxin (5 mM) potentiates contraction while inhibiting 
voltage-dependent tubular Ca2+ current in frog skeletal muscle fibers (Jacquemond et al. 
1996); it (10 µM) decreases the intensity of methylation of phospholipids 
(phosphatidylethanolamine) in rat olfactory cortex (Gerasimova et al. 1993). Another 
possibility is that ivermectin has action sites other than Cl- channels (Ellis et al. 1987; 
Sani and Vaid 1988; Ahern et al. 1999), thus a Cl- blocker can only reduce but not 
abolish the effect of ivermectin. 
lvermectin-sensitive c1- channels are present in nerve and/or muscle cells in many 
invertebrates, such as nematodes, insects, crustaceans, and mollusks (Cleland 1996). 
Although their physiological role has not been fully determined, they are reported to be 
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involved in generating rhythmic firing of the neurons within the crustacean 
stomatogastric ganglion (Cleland and Selverston, 1995, 1998). Our results showed that 
ivermectin decreased swimming frequency and crawling frequency, suggesting that 
ivermectin-sensitive Cl- channels are involved in the neuropathways that control 
swimming and crawling. 
It was interesting to observe that the escape reflex behavior controlled by giant 
interneuron pathways was still intact even after treatment with 300 nM ivermectin. 
Electrophysiological studies confirmed that ivermectin had no effects on the conduction 
velocity of MGF or LGF, or the muscle potentials evoked during multiple firing of MGF 
action potentials, suggesting that ivermectin-sensitive c1- channels are not crucially 
involved in the escape reflex functions of giant interneurons. This is not surprising if one 
takes a closer look at the giant interneuron system. The MGF and LGF pathways are 
derived from the electrically connected large axons of interneurons in each segment. 
They function as a syncytium, rapidly conducting nerve action potentials, without 
interruption, along their length (Drewes 1999b ). In such a straightforward system, the 
main emphasis seems to be speed and reliability; negative feedback via inhibition may be 
unnecessary or inconsequential. On the other hand, some locomotor behaviors controlled 
by non-giant interneuron pathways (swimming and crawling) are slower, rhythmic, and 
probably subject to modulatory influence. Specific networks of neurons in an animal's 
central nervous system, which control coordinated (and often rhythmic) pattern of 
movements, are termed central pattern generators (Young 1989). Negative feedback and 
other modulatory controls are usually utilized in such networks. 
It has been reported that ivermectin has inhibitory effects on the pharyngeal muscle 
through opening Cl- channels in the parasitic nematode Ascaris suum (Adelsberger et al. 
1997; Brownlee et al. 1997). In Lubriculus, muscle potentials are normally associated 
with repetitive MGF spikes, but our results showed no significant changes in the 
appearance of these potentials following ivermectin treatment. However, our 
observations were based on muscle activities recorded from the body surface. This 
method is indirect, and may not sufficiently sensitive to detect subtle changes in 
membrane potential of muscle fibers. 
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CONCLUSIONS 
In conclusion, our results demonstrated that (1) sublethal behavioral effects were 
much more sensitive endpoints than was mortality in assessing ivermectin's potential 
neurobiological and ecological impacts; (2) locomotor behaviors controlled by non-giant 
intemeuron pathways were sensitive to ivermectin whereas those controlled by giant 
intemeurons did not appear to be affected at the concentrations studied; and (3) er 
channels appeared to be involved in ivermectin's inhibitory effects. 
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